ByteBrief
We're a portrait publication through and through. Turn your phone back and your briefing picks up right where you left it.
(We tried widescreen once. It wasn't us.)

About half of 215 surveyed Society of Breast Imaging members use FDA-approved AI tools for breast cancer detection. Only 35 percent report lower recall rates, while 59 percent expected them, showing results fall short of expectations across all measured categories.
Tap to vote and see what everyone thinks.
Summary by ByteBrief